In this episode we go over FDA approval of Koselugo for the treatment of pediatric patients with neurofibromatosis type 1, as well as new indications for Reblozyl and Braftovi. We’ll also talk about the most recent ranitidine recall and as usual, we'll be giving an update on the coronavirus epidemic and flu season to date, including an expanded scope for pharmacists to actually administer COVID19 tests. Don't forget to like, share, and subscribe! Enjoy!